TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Eisenmann, ED; Stromatt, JC; Fobare, S; Huang, KM; Buelow, DR; Orwick, S; Jeon, JY; Weber, RH; Larsen, B; Mims, AS; Hertlein, E; Byrd, JC; Baker, SD

Baker, SD (通讯作者)，Ohio State Univ, Div Pharmaceut & Pharmacol, Columbus, OH 43212 USA.

CANCERS, 2023; 15 (1):

Abstract

Simple Summary Acute myeloid leukemia (AML) with mutations in the tumor suppressor gene TP53 is rapidly lethal for most patients. Here, we investigate......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索